These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25429401)

  • 1. Chemotherapy in heterogeneous cultures of cancer cells with interconversion.
    Dilão R
    Phys Biol; 2014 Nov; 12(1):016002. PubMed ID: 25429401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for cancer stem cell elimination: insights from mathematical modeling.
    Vainstein V; Kirnasovsky OU; Kogan Y; Agur Z
    J Theor Biol; 2012 Apr; 298():32-41. PubMed ID: 22210402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs.
    Chen L; Xiao Z; Meng Y; Zhao Y; Han J; Su G; Chen B; Dai J
    Biomaterials; 2012 Feb; 33(5):1437-44. PubMed ID: 22078807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells: the development of new cancer therapeutics.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell targeted agents: therapeutic approaches and consequences.
    Chumsri S; Burger AM
    Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolution.
    Afrimzon E; Botchkina G; Zurgil N; Shafran Y; Sobolev M; Moshkov S; Ravid-Hermesh O; Ojima I; Deutsch M
    Lab Chip; 2016 Mar; 16(6):1047-62. PubMed ID: 26907542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 8. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
    Sánchez-García I; Vicente-Dueñas C; Cobaleda C
    Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells and differentiation therapy.
    Sell S
    Tumour Biol; 2006; 27(2):59-70. PubMed ID: 16557043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective killing of cancer stem cells by a novel dual-targeting strategy.
    Lou D; Wang B; Wang Y; Cao Y
    Med Hypotheses; 2012 Oct; 79(4):430-2. PubMed ID: 22818853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of cancer stem cell-like cells by culture in alginate gel beads.
    Xu XX; Liu C; Liu Y; Yang L; Li N; Guo X; Sun GW; Ma XJ
    J Biotechnol; 2014 May; 177():1-12. PubMed ID: 24607645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and issues in cancer stem cell study.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
    Lim YC; Oh SY; Kim H
    Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
    Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.
    Lee CH; Yu CC; Wang BY; Chang WW
    Oncotarget; 2016 Jan; 7(2):1215-26. PubMed ID: 26527320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.